Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide Autogel for Symptomatic Treatment of Refractory Diarrhea
2009-009356-20Phase 2Completed
- Sponsor
- Ipsen
- Start
- May 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lanreotide in diarrhea, sponsored by Ipsen. Primary endpoint: Change in stool frequency at day 28. Started May 2009; status: completed.
02
Drugs
lanreotide
03
Conditions
diarrhea
Beyond the preview
Go deeper on 2009-009356-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009356-20.